H. Lundbeck Navne-Aktier Stock News & Updates

[WKN: A3DMBV | Symbol: HLUN/B]

H. Lundbeck A/S: Revenue from Vyepti for {[Migraine Prophylaxis]} Increases by 57% and Allows for Forecast Revision!

H. Lundbeck A/S is an internationally operating pharmaceutical company headquartered in Denmark, specializing...

H. Lundbeck A/S: Pro-Cyclical Buy Signal From Breakout Above Resistance Line!

On May 14, H. Lundbeck A/S Navne-Aktier B (i.) drew attention with better than expected Q1 results and...

  • 1